AONN+ and Manta Cares Bring AI Cancer Tool to 9,000 Navigators

Two organizations focused on cancer care have joined forces to address a growing gap in how patients access reliable information about their disease. AONN+, a professional association for oncology navigators, and Manta Cares, an AI health technology company, announced a collaboration aimed at equipping more than 9,000 oncology nurse and patient navigators across the United States with artificial intelligence resources purpose-built for cancer care.

The partnership comes as patients are increasingly turning to general-purpose AI platforms — tools not designed with oncology-specific accuracy or safety guardrails in mind — to research diagnoses, treatment options, and side effects. Healthcare professionals who work as navigators serve as critical guides through what can be an overwhelming care journey, making their access to vetted AI resources particularly consequential for patient outcomes.

Read more IBM Adds Private Equity Executive Frank Baker to Board →

Under the agreement, AONN+ members will receive training and education alongside access to Manta Cares' AI tool, which is specifically designed for the cancer context. The move reflects a broader effort within oncology care to channel the rapid adoption of AI toward clinically appropriate, safe applications rather than leaving patients and their care teams to navigate a fragmented landscape of general-purpose technology.

The scale of the initiative — reaching navigators who collectively support a substantial portion of the U.S. cancer patient population — signals growing institutional recognition that AI governance in sensitive medical settings requires specialty-specific solutions. Whether partnerships of this kind become a model for other disease areas remains to be seen, but the AONN+–Manta Cares collaboration represents one of the more concrete moves yet to standardize AI use among frontline oncology support staff.

Continue reading at GlobeNewswire - Industry News on Financial Services.